Caldino Tablets (Calidinomagenase)

Adult dose

Administer 30-150 I.U. per day orally in 3 divided doses. The dose may be adjusted appropriately according to age and symptoms.

This medication should not be used in patients with recent cerebral hemorrhage or those with active bleeding. Additionally, because this medication contains lactose, patients with genetic disorders that prevent lactose breakdown should not take this medication. Allergic reactions may occur when taking this medication; if a skin rash or itching develops, discontinue use immediately. Symptoms of a rapid heartbeat may occasionally appear, so caution is advised. Gastrointestinal symptoms such as discomfort in the stomach, nausea, vomiting, loss of appetite, abdominal pain, diarrhea, or constipation may occur occasionally. Other rare symptoms may include fever, headache, a feeling of heaviness in the head, drowsiness, or fatigue. Particularly, older patients may have decreased physical function, so careful attention is required when using this medication, such as reducing the dose.

• rash
• itching
• palpitations
• abdominal discomfort
• nausea
• vomiting
• loss of appetite
• upper abdominal pain
• diarrhea
• constipation

Store this medication in a sealed container to prevent air exposure and keep it at room temperature between 1 to 30 degrees Celsius. This storage method helps maintain the medication's effectiveness and prevent deterioration.

Appearance

White, round enteric-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle